Type 2 diabetes hits women differently.

And harder.

Women with type 2 diabetes face higher cardiovascular risk and unique hormonal drivers of insulin resistance.


Download a free clinical toolkit to support patients with structured, evidence-based metabolic care.

Type 2 diabetes hits women differently. And harder.

Women with type 2 diabetes face higher cardiovascular risk and unique hormonal drivers of insulin resistance.


Download a free clinical toolkit to support patients with structured, evidence-based metabolic care.

Type 2 diabetes hits women differently. And harder.

Women with type 2 diabetes face higher cardiovascular risk and unique hormonal drivers of insulin resistance.

Download a free clinical toolkit to support patients with structured, evidence-based metabolic care.

Women and insulin resistance

Women with type 2 diabetes face a higher risk of serious complications.

Customers served! 0 % Higher risk of CVD than men with diabetes
Customers served! 0 % Higher risk of stroke than men with diabetes
Customers served! 0 x PCOS increases risk of type 2 diabetes
Customers served! 0 % Increased risk of metabolic syndrome post menopause

How the Defeat Diabetes Program helps your patients

Built on Therapeutic Carbohydrate Reduction (TCR), an evidence-based approach shown to improve glycaemic control and reduce medication reliance, the program complements clinical care rather than replacing it. 

  • Structured learning

Education on insulin resistance and the evidence for low carb.

  • Practical & simple 

Simple guidance on meal planning, glucose monitoring and habit formation.

  • Behavioural support

Tools and resources that support sustainable change.

  • Measurable outcomes

Tracking of HbA1c, weight and medication use alongside their healthcare provider.

Real-world outcomes

An independent 12-month study from La Trobe University showed significant improvements in HbA1c, weight and metabolic health for participants following the Defeat Diabetes Program:

52%
returned blood glucose to non-diabetic range
32%
stopped or reduced medication
85%
improved glycaemic control 

Our offer to you

  • 12-months complimentary access to the Defeat Diabetes Program
  • 15% discount for patients 
  • The evidence for TCR
  • Deprescribing guide 
  • Introduction to TCR eBook 
  • Patient downloadables

Built for type 2 diabetes. Relief for menopause.

Ease the hormonal chaos of menopause for patients by improving insulin sensitivity, reducing inflammation and aiding weight loss through sustainable dietary modifications. No calorie counting. No fads. Just simple changes that actually work.

Stubborn weight

Break the cycle of insulin-driven weight gain for patients.

Balance hormones

Improve insulin sensitivity, support estrogen and more.

Improve mental health

Clearer thinking, better focus, brighter mood.

Ease symptoms

Lower inflammation and hormonal swings.

"In two months, I went from night sweats and poor sleep to 6–7 hours a night. My mood lifted, brain fog cleared and the aches disappeared."

Get your FREE TCR Toolkit

Everything you need to start transforming women's lives today

Real women. Real results.

Improved blood glucose, diabetes remission, more energy, better sleep, steady weight, brighter mood. This is what’s possible when women support their bodies in the right way.

Australia’s most trusted type 2 diabetes program

Doctor developed. Clinically proven. Member loved.

Customers served! 0 Stars

Average Apple star rating

Customers served! 0 Stars

Members helped

Customers served! 0 + Stars

Endorsed by doctors

Improve on the standard model of care

An independent clinical study found that patients following the Defeat Diabetes Program achieved significantly better clinical outcomes compared to standard care.

HBA1C

1%

percentage reduction

Standard care: +0.2%1

MEDICATION

32%

reduced medication use

Standard care: +9%1

REMISSION

52%

achieved remission2

Standard care: 0.2%3

HBA1C

1%

percentage reduction

Standard care: +0.2%1

MEDICATION

32%

reduced medication use

Standard care: +9%1

REMISSION

52%

achieved remission2

Standard care: 0.2%3

CITATIONS:

  1. HbA1c & medication in standard care: Saslow LR, Summers C, Aikens JE, Unwin DJ Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study, JMIR Diabetes. doi:10.2196/diabetes.9333
  2. HbA1c & medication in standard care: Saslow LR, Summers C, Aikens JE, Unwin DJ Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study, JMIR Diabetes. doi:10.2196/diabetes.9333
  3. Nutrients, 07/03/25, A 6-Month mHealth Low-Carbohydrate Dietary Intervention Ameliorates Glycaemic and Cardiometabolic Risk Profile in People with Type 2 Diabetes, https://www.mdpi.com/2072-6643/17/6/937
  4. Remission in standard care: https://pubmed.ncbi.nlm.nih.gov/25231895/
  5. Nutrients, 07/03/25, A 6-Month mHealth Low-Carbohydrate Dietary Intervention Ameliorates Glycaemic and Cardiometabolic Risk Profile in People with Type 2 Diabetes, https://www.mdpi.com/2072-6643/17/6/937
  6. HbA1c & medication in standard care: Saslow LR, Summers C, Aikens JE, Unwin DJ Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study, JMIR Diabetes. doi:10.2196/diabetes.9333
  7. Nutrients, 07/03/25, A 6-Month mHealth Low-Carbohydrate Dietary Intervention Ameliorates Glycaemic and Cardiometabolic Risk Profile in People with Type 2 Diabetes, https://www.mdpi.com/2072-6643/17/6/937
  8. Remission in standard care: https://pubmed.ncbi.nlm.nih.gov/25231895/
  9. Remission in standard care: https://pubmed.ncbi.nlm.nih.gov/25231895/

>